Evidence map›Paper›PMID 29324749›Full record

ArticlePloS one2018

Brand switching and toxic chemicals in cigarette smoke: A national study.

Jennifer R Mendel, Sabeeh A Baig, Marissa G Hall, Michelle Jeong, M Justin Byron, Jennifer C Morgan, Seth M Noar, Kurt M Ribisl, Noel T Brewer

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Sociodemographic and Smoking Characteristics Associated With Low Perceived Harm of "Organic" and "Additive-Free" Tobacco Products Among US Adults.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Similarities and Differences in Tobacco Control Research Findings From Convenience and Probability Samples.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jennifer R MendelLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.ORCID 0000-0002-2499-2871
Sabeeh A BaigDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States of America.
Marissa G HallLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
Michelle JeongLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
M Justin ByronLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
Jennifer C MorganDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States of America.
Seth M NoarLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
Kurt M RibislLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
Noel T BrewerLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
University of North Carolina at Chapel Hill · US

Funding

Training & Education Program p294-308P50CA180907 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RIBISL, KURT M. · 2013 to 2017
$20.2M
Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
NCI NIH HHS P50 CA180907NCI NIH HHS T32 CA057726NIH HHS P50CA180907NIH HHS T32-CA057726
6 · The paper itself

Abstract

introductionUS law requires disclosure of quantities of toxic chemicals (constituents) in cigarette smoke by brand and sub-brand. This information may drive smokers to switch to cigarettes with lower chemical quantities, under the misperception that doing so can reduce health risk. We sought to understand past brand-switching behavior and whether learning about specific chemicals in cigarette smoke increases susceptibility to brand switching.

methodsParticipants were US adult smokers surveyed by phone (n = 1,151, probability sample) and online (n = 1,561, convenience sample). Surveys assessed whether smokers had ever switched cigarette brands or styles to reduce health risk and about likelihood of switching if the smoker learned their brand had more of a specific chemical than other cigarettes. Chemicals presented were nicotine, carbon monoxide, lead, formaldehyde, arsenic, and ammonia.

resultsPast brand switching to reduce health risk was common among smokers (43% in phone survey, 28% in online survey). Smokers who were female, over 25, and current "light" cigarette users were more likely to have switched brands to reduce health risks (all p < .05). Overall, 61-92% of smokers were susceptible to brand switching based on information about particular chemicals. In both samples, lead, formaldehyde, arsenic, and ammonia led to more susceptibility to switch than nicotine (all p < .05).

conclusionsMany US smokers have switched brands or styles to reduce health risks. The majority said they might or would definitely switch brands if they learned their cigarettes had more of a toxic chemical than other brands. Brand switching is a probable unintended consequence of communications that show differences in smoke chemicals between brands.

Indexed as

AdolescentAdultAgedAmmoniaArsenicCarbon MonoxideFemaleFormaldehydeHumansLeadMaleMiddle AgedNicotineSmokeTobacco ProductsUnited StatesAmmoniaArsenicCarbon MonoxideFormaldehydeLeadNicotineSmoke

Identifiers

PMID29324749
PMCPMC5764241
OpenAlexW2782608010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.